Candidemia has been considered a persistent public health problem with great impact on hospital costs and high mortality. We aimed to evaluate the epidemiology and prognostic factors of candidemia in a tertiary hospital in Northeast Brazil from January 2011 to December 2016. Demographic and clinical data of patients were retrospectively obtained from medical records and antifungal susceptibility profiling was performed using the broth microdilution method. A total of 68 episodes of candidemia were evaluated. We found an average incidence of 2.23 episodes /1000 admissions and a 30-day mortality rate of 55.9%. The most prevalent species were
Candida albicans
(35.3%),
Candida tropicalis
(27.4%),
Candida parapsilosis
(21.6%) and
Candida glabrata
(11.8%). Higher mortality rates were observed in cases of candidemia due to
C
.
albicans
(61.1%) and
C
.
glabrata
(100%), especially when compared to
C
.
parapsilosis
(27.3%). Univariate analysis revealed some variables which significantly increased the probability of death: older age (
P
= 0.022; odds ratio [OR] = 1.041), severe sepsis (
P
< 0.001; OR = 8.571), septic shock (
P
= 0.035; OR = 3.792), hypotension (
P
= 0.003; OR = 9.120), neutrophilia (
P
= 0.046; OR = 3.080), thrombocytopenia (
P
= 0.002; OR = 6.800), mechanical ventilation (
P
= 0.009; OR = 8.167) and greater number of surgeries (
P
= 0.037; OR = 1.920). Multivariate analysis showed that older age (
P
= 0.040; OR = 1.055), severe sepsis (
P
= 0.009; OR = 9.872) and hypotension (
P
= 0.031; OR = 21.042) were independently associated with worse prognosis. There was no resistance to amphotericin B, micafungin or itraconazole and a low rate of resistance to fluconazole (5.1%). However, 20.5% of the
Candida
isolates were susceptible dose-dependent (SDD) to fluconazole and 7.7% to itraconazole. In conclusion, our results could assist in the adoption of strategies to stratify patients at higher risk for developing candidemia and worse prognosis, in addition to improve antifungal management.
Vulvovaginal candidiasis (VVC) is one of the most common causes of vaginitis and affects about 75 % of women of reproductive age. In order to better understand the epidemiology and pathogenesis of this disease, we evaluated genetic relatedness among 62 clinical isolates of Candida albicans sequentially obtained from the anus and vagina of patients with sporadic and recurrent VVC. Evaluation of patients' demographic and clinical data, direct examination, and colony forming units (c.f.u.) counts of vaginal and anal samples were also performed. The genotypes of strains were determined with ABC genotyping and Randomly Amplified Polymorphic DNA (RAPD). Genotype A was the most prevalent (93.6 %), followed by genotype C (6.4 %), whereas genotype B was not found. We found the maintenance of the same ABC genotype, regardless of the body site of each patient. Most of the vaginal strains suffered microevolution, whereas most of the anal strains were replaced during the period of study. Vaginal and anal isolates of C. albicans obtained simultaneously from the same patient showed the same ABC genotype and high genetic similarity as determined by RAPD. Genotype A seemed to be dominant in both vaginal and anal isolates of patients with VVC. Our results corroborate the hypothesis that there are 'substrains' of the C. albicans vaginal clone successfully established, which dominate in an apparently random manner over the course of time. It is suggested that the anal reservoir constitutes a possible source for vaginal infection in most of the cases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.